Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug-induced pulmonary disease.

J A Cooper, R A Matthay

    Disease-A-Month : DM
    |February 1, 1987
    PubMed
    Summary

    Over 40 drugs can cause pulmonary toxicity, leading to potentially fatal lung conditions. Understanding drug-induced lung damage mechanisms and clinical signs is crucial for patient care.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The immunological synapse and the actin cytoskeleton: molecular hardware for T cell signaling.

    Nature immunology·2001
    Same author

    TOR signaling regulates microtubule structure and function.

    Current biology : CB·2000
    Same author

    Microtubule interactions with the cell cortex causing nuclear movements in Saccharomyces cerevisiae.

    The Journal of cell biology·2000
    Same author

    Molecular switches in lipid rafts.

    Nature·2000
    Same author

    Role of actin and Myo2p in polarized secretion and growth of Saccharomyces cerevisiae.

    Molecular biology of the cell·2000
    Same author

    Pulmonary fibrosis: pathways are slowly coming into light.

    American journal of respiratory cell and molecular biology·2000

    Area of Science:

    • Pulmonology
    • Pharmacology
    • Toxicology

    Background:

    • Over 40 pharmacologic agents are linked to pulmonary toxicity, a growing clinical concern.
    • Drug-induced pulmonary side effects can necessitate treatment withdrawal, risking patient health.
    • Irreversible lung damage from medications presents a significant therapeutic challenge.

    Purpose of the Study:

    • To review the mechanisms of drug-induced pulmonary parenchymal injury.
    • To outline the clinical syndromes associated with medication-induced lung damage.
    • To assist clinicians in recognizing and managing these adverse events.

    Main Methods:

    • Literature review of drug-induced pulmonary toxicity.
    • Analysis of mechanisms causing direct and indirect lung injury.
    • Compilation of clinical syndromes and risk factors.

    Main Results:

    • Drugs can cause direct tissue injury or indirect damage via inflammation.
    • Common syndromes include pneumonitis/fibrosis, hypersensitivity lung disease, and pulmonary edema.
    • Less common patterns involve bronchiolitis obliterans and pulmonary renal syndrome.

    Conclusions:

    • Drug-induced pulmonary disease is complex, with varied mechanisms and presentations.
    • Early detection methods are lacking, highlighting the need for clinical vigilance.
    • Understanding these syndromes aids in timely diagnosis and management of lung injury from medications.

    Related Experiment Videos